Preliminary reports suggest conolidine may inhibit unique ion channels, minimizing neuronal excitability and limiting discomfort alerts. This system is particularly appropriate in neuropathic pain, wherever irregular signaling causes persistent pain. On top of that, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to ache perception. Computational docking https://jimmyy813gcx3.wikissl.com/user